1. Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
- Author
-
Ashlee Matkin, Hadi Seikaly, Jordana Williams, Morris Kostiuk, Daniel A. O’Connell, Brandon R. Rosvall, Vincent L. Biron, and Jeffrey R. Harris
- Subjects
Oncology ,Thyroid nodules ,Male ,Proto-Oncogene Proteins B-raf ,Cancer Research ,medicine.medical_specialty ,TERT ,Bethesda system ,ddPCR ,Malignancy ,Polymerase Chain Reaction ,BRAF ,Surgical pathology ,Internal medicine ,Cytology ,Biopsy ,Genetics ,medicine ,Humans ,Thyroid Nodule ,Thyroid cancer ,Telomerase ,RC254-282 ,Cancer ,Thyroid ,medicine.diagnostic_test ,business.industry ,Research ,Molecular ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Middle Aged ,medicine.disease ,medicine.anatomical_structure ,PCR ,Mutation ,Female ,business - Abstract
Background Mutations involving BRAF and TERT are important predictors of disease severity in thyroid cancer, but molecular testing is limited by cost and lack of adequate tissue sample. This study aimed to assess the utility of BRAFV600E and TERT testing using droplet digital PCR (ddPCR) as a diagnostic and prognostic tool for thyroid fine needle aspirate biopsy (FNAB). Methods Patients with thyroid nodules were prospectively enrolled from March 2015 to September 2018. Pre-operative FNAB was collected for standard cytology and molecular testing. BRAFV600E and TERT levels were analyzed by ddPCR. Cytology (Bethesda system) and ddPCR results were correlated to surgical pathology. Results A total of 222 patients were enrolled, of which 124 received thyroid surgery. Pre-operative cytology alone with Bethesda ≥5 was 100% specific and 70% sensitive for malignancy on final surgical pathology. BRAFV600E positivity or TERT overexpression was 100% specific and 60.0% sensitive. Combining cytology (Bethesda ≥5) with BRAFV600E and TERT testing increased the sensitivity of a malignant diagnosis to 80.0%. High TERT levels and/or BRAFV600E was associated with aggressive or advanced stage pathology. Conclusions Combining cytology with ddPCR analysis of BRAFV600E and TERT can improve the diagnostic accuracy of thyroid FNAB, and help predict aggressive pathology.
- Published
- 2021